Techno Medicine Shifts Costs and Risks to Patients

FDA posted a “new paradigm” for public consideration – one in which routine diagnostic and treatment decisions would shift from our physicians to patients and pharmacists and/or other technologies.

At Allergy & Asthma Day Capitol Hill, May 9, 2013, Allergy & Asthma Network Mothers of Asthmatics is asking Congress to take asthma and anaphylaxis medications out of the FDA paradigm.

Read more:

• FDA’s proposal in its Feb. 28, 2012 Federal Register: Using Innovative Technologies and Other Conditions of Safe Use to Expand Drug Products Considered Nonprescription.
• Do-It-Yourself Asthma? Interview with Janet Woodcock, MD, Director of FDA’s Center for Drug Evaluation and Research; first published in Allergy & Asthma Today, Fall 2012
• “FDA proposal threatens access to care for asthma and allergy patients,” Nancy Sander Op-Ed published in The Hill newspaper, May 2012
• Our article “FDA’s Proposed New Paradigm,” written in response to the proposal and FDA’s March 2012 Public Hearing. First published in Allergy & Asthma Today Summer 2012.
• AANMA’s Allergy & Asthma Families Care Survey - results overview.

Public Hearing Testimony in response to FDA’s proposal:

• Transcript of AANMA’s testimony during the FDA March 2012 Public Hearing — click on “Transcript Day 1 – March 22, 2012″ and scroll to page 84 to read Nancy Sander’s testimony and view her slideshow presentation.
• The American Lung Association - position on FDA proposal
• The American Thoracic Society position on FDA proposal
• PhRMA – Pharmaceutical Research and Manufacturing Association — position on FDA proposal.
• Teva Pharmaceuticals – position on FDA proposal

What you can do:

• Join AANMA to support our advocacy efforts and keep up to date on issues that affect you and your family. You’ll receive our award-winning newsletter and magazine straight to your mailbox, as well as e-mail alerts about ongoing issues.
• Share information on this issue with friends, family and medical care providers. Print out copies of these articles or send them links to this website.
• Bookmark AANMA’s website, www.aanma.org, and this Advocacy page and check it often for updated information on this issue and on Allergy & Asthma Day Capitol Hill 2013.